This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
June 19, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it received Registered Solutions Provider Status for Define.XML. This registration increases DATATRAK's total to five - CDASH, LAB, ODM, SDTM and Define.XML.
Define.XML is an XML-based submission of the study's metadata. The Define.XML file provides Case Report Tabulations Data Definitions in an XML format for submission to regulatory authorities (e.g., FDA). This list of the datasets included in the submission also provides a detailed description of the contents of each dataset.
"As a longstanding member of the CDISC Advisory Board, DATATRAK's certification on another CDISC standardization is especially gratifying," stated
Chris Wilke, DATATRAK's Chief Technology Officer. "The completion of this new status exemplifies our leadership in cloud-based unified clinical research technology and our support of standards. It also re-enforces DATATRAK's continued commitment to provide new methods for increasing customer productivity and satisfaction."
About DATATRAK DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in
Bryan, Texas; and Cary (RTP),
North Carolina. For more information, visit
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on
May 10, 2012 announcing its results for the three-month period ending
March 31, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.